ABBV-291 clinical trials

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

This study is looking at a new medicine called ABBV-291 for adults with a type of cancer called Non-Hodgkin's Lymphoma. It aims to check if the medicine is safe, what dose works best, and if it helps to treat the cancer that has come back or hasn’t responded to other treatments.